Cardinal Health 2009 Annual Report Download - page 37

Revenue and Long-Lived Assets by Geographic Area
For information on revenue and long-lived assets by geographic area, see Note 17 of “Notes to Consolidated
Financial Statements,” which is incorporated herein by reference.
Available Information and Exchange Certifications
The Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on
Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), are made available free of charge on the Company’s
website (www.cardinalhealth.com, under the “Investors—Financials/SEC filings” captions) as soon as
reasonably practicable after the Company electronically files these materials with, or furnishes them to, the
Securities and Exchange Commission (the “SEC”).
You may read and copy any materials the Company files with the SEC at the SEC’s Public Reference Room
at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public
Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains
reports, proxy and information statements, and other information regarding the Company (http://www.sec.gov).
In addition, in connection with the Company’s planned Spin-Off of CareFusion, CareFusion has filed a
registration statement on Form 10 (File No. 001-34273) with the SEC. You may obtain additional information
regarding the Spin-Off and CareFusion by reviewing the registration statement.
The Company submitted the certification of its Chief Executive Officer required by Section 303A.12(a) of
the New York Stock Exchange (“NYSE”) Listed Company Manual, relating to the Company’s compliance with
the NYSE’s corporate governance listing standards, to the NYSE in December 2008 with no qualifications.
The Company included the certifications of its Chief Executive Officer and Chief Financial Officer required
by Section 302 of the Sarbanes-Oxley Act of 2002 and related rules, relating to the quality of the Company’s
public disclosure, in this Annual Report on Form 10-K as Exhibits 31.1 and 31.2.
Item 1A: Risk Factors
The risks described below could materially and adversely affect the Company’s results of operations,
financial condition, liquidity and cash flows. These risks are not the only risks that the Company faces. The
Company’s business operations could also be affected by additional factors that are not presently known to it or
that the Company currently considers not to be material to its operations.
Competitive pressures could adversely affect the Company’s results of operations and financial condition.
The Company operates in markets that are highly competitive. Its pharmaceutical supply chain business
competes with two national, full-line wholesale distributors, McKesson Corporation and AmerisourceBergen
Corporation, and a number of regional wholesale distributors, self-warehousing retail pharmacy chains, direct
selling manufacturers, specialty distributors, generic pharmaceutical telemarketing distributors and third-party
logistics companies, among others. The Company’s medical products distribution business encounters
competition from numerous and varied competitors in all areas of their businesses. As a result, the Company’s
businesses face continued pricing pressure from their customers. In some cases, the Company is able to offset
revenue reductions caused by these pricing pressures by lowering its costs through effective product sourcing and
cost controls. If the Company is unable to effectively mitigate future pricing pressures, its results of operations
and financial condition could be adversely affected. In addition, in recent years, the healthcare industry has been
subject to increasing consolidation. If this consolidation trend continues among the Company’s customers and
vendors, it could give the resulting enterprises greater bargaining power, which may adversely impact the
Company’s gross margin.
15